Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-09

Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of paclitaxel albumin-stabilized nanoparticle formulation in metastatic breast cancer across different ages; results are posted. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-08-09